List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1187 studies with search of: Interferon
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
2 Recruiting Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa-2a and ribavirin
3 Recruiting Interferon-Gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-Responders
Conditions: Hepatitis C;   Genotype 3;   Non-Responders;   Relapsers
Interventions: Drug: interferon alpha-2b, ribavirin, interferon-gamma,;   Drug: interferon alpha-2b, ribavirin, amantadine
4 Recruiting Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
Conditions: Adjuvant;   Stage III Malignant Melanoma;   Interferon Alpha;   Therapy
Intervention: Drug: Interferon-alpha-2b
5 Recruiting Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Dialysis Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a plus low dose ribavirin;   Drug: Pegylated interferon alfa
6 Completed
Has Results 		Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
Conditions: Chronic Hepatitis C;   Hemodialysis
Intervention: Drug: Pegylated interferon alfa-2a and ribavirin
7 Not yet recruiting Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: Influenza Vaccine Trivalent Inactivated (TIV);   Drug: Pegylated interferon (PEGrIFN-α, Pegasys);   Drug: Interferon (IFNα, Roferon-A)
8 Not yet recruiting Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer
Conditions: Brain and Central Nervous System Tumors;   Melanoma (Skin)
Interventions: Biological: recombinant interferon alfa-2b;   Drug: cisplatin;   Drug: sodium stibogluconate;   Drug: temozolomide;   Drug: vinblastine;   Genetic: gene expression analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Recruiting Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: alb-interferon alfa 2b;   Drug: peg-interferon
10 Completed Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
Condition: Chronic Hepatitis C
Intervention: Drug: Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks
11 Completed Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
Condition: Chronic Hepatitis C
Intervention: Drug: Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks
12 Terminated Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Decitabine;   Drug: Interferon Alfa-2b
13 Completed Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients
Conditions: HIV Infections;   Chronic Hepatitis C
Interventions: Drug: Interleukin 2;   Drug: pegylated interferon alpha 2a;   Drug: ribavirin
14 Completed Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens
Condition: Carcinoma, Renal Cell
Intervention: Drug: capecitabine, interferon-alpha
15 Recruiting Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Cutaneous Melanoma
Conditions: Metastatic Melanoma;   Cutaneous Melanoma
Interventions: Drug: Interferon alpha;   Drug: KW2871;   Drug: interferon alpha
16 Completed A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Interferon alfa-2a;   Drug: Zidovudine;   Drug: Interferon alfa-n1
17 Completed A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Interferon alfa-2a;   Drug: Zidovudine;   Drug: Interferon alfa-n1
18 Recruiting Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: pegylated interferon alpha and plus ribavirin
19 Recruiting Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial
Condition: Chronic Hepatitis C
Intervention: Drug: consensus interferon (Interferon Alfacon-1) and ribavirin
20 Recruiting Interferon-Alpha Lozenges for Prevention of Relapse in Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: interferon-alpha lozenges;   Drug: placebo lozenges

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services